Qingyang Que
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: January 25, 2024
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 25, 2023
mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma.
Journal: Molecular biomedicine
Published: October 02, 2023
Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria.
Journal: Nature communications
Published: June 30, 2023
Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
Journal: MedComm
Published: June 07, 2023
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.
Journal: World journal of surgical oncology
Published: December 25, 2022
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: March 16, 2022
Liver transplantation in patients with liver failure: Twenty years of experience from China.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026